Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.005 |
mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | 0.11 | 0.005 |
mRNA | ML162 | CTRPv2 | pan-cancer | AAC | 0.096 | 0.005 |
mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | 0.096 | 0.005 |
mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | 0.098 | 0.006 |
mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | 0.27 | 0.006 |
mRNA | BRD-K26531177 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.006 |
mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.006 |
mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.006 |
mRNA | JQ-1:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.093 | 0.007 |